Fny Investment Advisers, LLC Vbi Vaccines Inc Transaction History

Fny Investment Advisers, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.66 - $1.81 $3,300 - $9,050	-5,000 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$1.27 - $2.47 $10,160 - $19,760	-8,000 Reduced 61.54%	5,000 $8,000
Q4 2021 Jan 10, 2022	SELL	$2.21 - $3.22 $25,819 - $37,619	-11,683 Reduced 47.33%	13,000 $30,000
Q3 2021 Oct 13, 2021	SELL	$2.8 - $3.72 $106,400 - $141,360	-38,000 Reduced 60.62%	24,683 $76,000
Q2 2021 Jul 14, 2021	BUY	$2.61 - $4.17 $85,302 - $136,288	32,683 Added 108.94%	62,683 $209,000
Q1 2021 Apr 12, 2021	BUY	$2.91 - $4.32 $32,592 - $48,384	11,200 Added 59.57%	30,000 $93,000
Q4 2020 Jan 19, 2021	SELL	$2.15 - $3.5 $430 - $700	-200 Reduced 1.05%	18,800 $51,000
Q3 2020 Oct 09, 2020	BUY	$2.77 - $6.17 $13,825 - $30,794	4,991 Added 35.63%	19,000 $54,000
Q2 2020 Jul 10, 2020	BUY	$0.87 - $3.13 $12,187 - $43,848	14,009 New	14,009 $43,000
Q4 2018 Jan 22, 2019	SELL	$1.22 - $2.41 $6,100 - $12,050	-5,000 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$2.75 - $3.85 $13,750 - $19,250	5,000 New	5,000 $13,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.